Course & Conference Booklet
Download or view full Course & Conference Booklets below
Workshop Day 1: Lecture
24 Aug 2022
Part 1 – The Peritoneum
Part 2 – Peri and Intra-operative Considerations
Part 3 – Colorectal Cancer
Part 4 – Gastric Cancer
Lunch Symposium (Sponsored by Sanofi)
Part 5 – Pseudomxyoma Peritonei
Part 6 – Mesothelioma
Part 7 - Ovarian Cancer
Part 8 – Technical aspects
Workshop Day 2: Hands On
25 Aug 2022
PIPAC model
Central abdomen (omentum, small bowel) and flanks
Pelvis (bladder, THBSO, peritoneum)
Right upper abdomen (Liver capsule, Morison’s pouch, hepatoduodenal ligament)
Left upper abdomen (splenectomy, pancreas, stomach)
Central upper abdomen (portal triad, lesser sac, caudate lobe)
Set up of HIPEC
Conference Day 1:
26 Aug 2022
0815– 0830
Opening Speech by Clin. Assoc. Prof. Claramae Chia (Senior Consultant and Head of Department of Sarcoma, Peritoneal and Rare Tumours)
0830 – 0845
Welcome Speech by Prof. Ivy Ng (Group Chief Executive Officer, SingHealth)
Plenary lecture
0845– 0915
Priorities and Strategies in Setting Up a Comprehensive Peritoneal Centre
Speaker: Prof. Dr. med. Beate Rau
0915 – 0945
Thinking outside the box: What HIPEC can and cannot be expected to do
Speaker: Prof. Paul Sugarbaker
0945 – 1015
Latest innovations and inventions to facilitate care in patients with peritoneal metastases
Speaker: Prof. Dr. med. Marc Raymond
1015 - 1030
Q&A
1030 – 1100
Tea Break
Gynae Session
1100 - 1130
Surgical Strategies for Stage 4 Ovarian Cancer
Speaker: Prof. Dennis Chi
1130- 1200
Harnessing Biomarkers and Molecular Genetics for Therapy in Ovarian Cancers
Speaker: Assoc. Prof. David Tan
1200 - 1230
Role of Surgery for Ovarian Cancer in the New Era of Targeted and Immunotherapy
Speaker: Prof. Willemien van Driel
1230 -1245
Q&A
1245- 1330
Lunch
1330 -1430
Lunch Symposium
(Sponsored by AstraZeneca)
Integrating PARPi Therapy into the Treatment of Ovarian Cancer
Chairperson: Dr Jack Chan
Speaker: Dr Robert Coleman
Breakout Rooms
1430 - 1500
Room 1
Pressurized Intraperitoneal Aerosolized Chemotherapy: How I do it Demonstrator and Speaker: Prof. Jimmy So
Room 2
Pearls of Cytoreductive Surgery and HIPEC
Demonstrator and Speaker: Clin. Assoc. Prof. Claramae Chia
Room 3
Poster Presentation of selected abstracts
1500-1530
Tea Break
Science Session
1530 – 1630
Implications of the genomic landscape of peritoneal metastases on diagnosis, therapy and way forward
Speaker: Prof. Jaffer Ajani
1630 – 1700
Biological hallmarks of peritoneal carcinomatosis
Speaker: Asst. Prof. Raghav Sundar
1700 – 1730
Getting the drug to the disease- Challenges and Future potential applications
Speaker: Prof. Dr. Wim Ceelen
1730 – 1800 A prospective study evaluating the role of ligand inhibition of paracrine factors in ascites
Speaker: Asst. Prof. Johnny Ong
1800 - 1815
Q&A
Conference Day 2:
27 Aug 2022
Gastric and Colorectal Session
0830 - 0900
Targeted Therapy, biologics and immunotherapy for gastrointestinal peritoneal metastases
Speaker: Prof. Dr. med. Florian Lordick
0900 -0930
Surgical Advances and algorithms in the treatment of gastric peritoneal metastases
Speaker: Dr. Vahan Kepenekian
0930 -1000
Latest evidence in the treatment of gastric peritoneal metastases
Speaker: Prof. Hironori Ishigami
1000 – 1030
Making sense of Evidence Based Medicine for Colorectal Peritoneal Carcinomatosis
Speaker: Dr. Delia Cortes Guiral
1030-1045
Q&A
1045 -1115
Tea Break
Palliative Care Session
1115 -1145
Parenteral and Enteral Nutrition for Patients with Peritoneal Carcinomatosis: Choices and Pitfalls
Speaker: Clin. Asst. Prof. Ennaliza Salazar
1145– 1215
Comprehensive Palliative Care for Peritoneal Carcinomatosis
Speaker: Clin. Asst. Prof. Zhou Xuelian Jamie
1215 – 1245
Psychosocial Considerations in Complex Oncology Patients
Speaker: Dr. Irene Teo Eng Ai
1245-1300
Q&A
1300 – 1345
Lunch
Lunch Symposium
(Sponsored by Bristol-Myers Squibb)
1345 – 1350
Welcome and Introduction
1350 - 1400
Surgical perspectives on management of resectable oesophageal cancer
Speaker: Dr Grace Tan
1400 - 1435
Immunotherapy: The new frontier for resectable oesophageal cancer
Dr Ken Kato
1435-1445
Q&A discussion
PMP and Mesothelioma Session
1445 – 1515
Rare indications for CRS and HIPEC for peritoneal metasteses
Speaker: Dr. Vahan Kepenekian
1515 – 1545
Management of mesotheliomas: Prognostication and successful therapies
Speaker: Prof. Marcello Deraco
1545 - 1600
Q&A